Cantitate/Preț
Produs
Total produse
Vezi coșul
Profiles of Drug Substances, Excipients, and Related Methodology de Harry G. Brittain

Profiles of Drug Substances, Excipients, and Related Methodology: Profiles of Drug Substances, Excipients and Related Methodology, cartea 45

Editat de Harry G. Brittain
en Limba Engleză Hardback – 10 mar 2020
Profiles of Drug Substances, Excipients, and Related Methodology, Volume 45, presents comprehensive reviews of drug substances and additional materials, with critical review chapters that summarize information related to the characterization of drug substances and excipients. The series encompasses review articles, with this release focusing on Azilsartan Medoxomil, Piroxicam, Carbetapentane Citrate, Emtricitabine, Etrlotinib, Isotretinoin and Meloxicam.


  • Contains contributions from leading authorities
  • Informs and updates on all the latest developments in the field of drug substances, excipients and methodologies
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Hardback (4) 87430 lei  5-7 săpt.
  ELSEVIER SCIENCE – 2 aug 2013 87430 lei  5-7 săpt.
  ELSEVIER SCIENCE – 19 apr 2017 102690 lei  5-7 săpt.
  ELSEVIER SCIENCE – 10 mar 2020 104818 lei  5-7 săpt.
  ELSEVIER SCIENCE – 24 apr 2019 111599 lei  5-7 săpt.

Din seria Profiles of Drug Substances, Excipients and Related Methodology

Preț: 104818 lei

Preț vechi: 144677 lei
-28% Nou

Puncte Express: 1572
Preț estimativ în valută:
20059€ • 20916$ • 16671£

Carte tipărită la comandă

Livrare economică 14-28 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780128203231
ISBN-10: 0128203234
Pagini: 494
Dimensiuni: 152 x 229 mm
Greutate: 0.83 kg
Editura: ELSEVIER SCIENCE
Seria Profiles of Drug Substances, Excipients and Related Methodology

Public țintă

Medicinal, pharmaceutical, and analytical chemists; pharmacologists

Cuprins

1. Azilsartan Medoxomil
Abdulrahman Al-Majed, Ali Al-Muhsin, Ahmed H. H. Bakheit, Hamad Al-kahtani, and Ali S. Abdelhameed
2. Carbetapentane Citrate
Ahmed S. Abo Dena, Alaa M. Ali, and Ibrahim M. El-Sherbiny
3. Emtricitabine
Abdulrahman A. Al-Majed, Ahmed H. H. Bakheit, Hamad M. Al-Kahtani, Bakr Mohammed Al-Qahtani, and Ali S. Abdelhameed
4. Erlotinib
Ahmed A. Abdelgalil, Hamad M. Alkahtani, and Fahad I. Al-Jenoobi
5. Isotretinoin
Nasr Y. Khalil, Ibrahim A. Darwish, and Abdulmohsen A. Al-Qahtani
6. Meloxicam
Nasr Y. Khalil and Khalid F. Aldosari
7. Piroxicam
Gamal A. E. Mostafa, Abdullah S. Al-Dosseri, and Abdullah A. Al-Badr